Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...
New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...
The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.
CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...
Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
PSA levels can be elevated for reasons other than cancer, such as an enlarged or inflamed prostate. False positive and false negative PSA test results are possible. The American Cancer Society does ...
A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...
"A lot of people assume that if their doctor doesn't bring up prostate cancer screening, it must not be important. But sometimes there just isn't enough time during a visit,” Sh ...
Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results